EQRx, Inc.
EQRXDelisted Nov 9, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001843762
EQRx, Inc. was delisted on Nov 9, 2023; its insiders filed their last Form 4 on Nov 14, 2023; 132 institutions reported holding it in 13F filings for Q3 2023, worth $768.6M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by EQRx, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for EQRx, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Casdin Eli | 10% Owner | 0Indirect | Nov 14, 2023 | 0 |
| Andreessen Marc L | 10% Owner | 0Indirect | Nov 9, 2023 | 0 |
| Horowitz Benjamin A | 10% Owner | 0Indirect | Nov 9, 2023 | 0 |
| Andreessen Horowitz LSV Fund I, L.P. | 10% Owner | 0Indirect | Nov 9, 2023 | 0 |
| AH Equity Partners LSV I, L.L.C. | 10% Owner | 0Indirect | Nov 9, 2023 | 0 |
| Andreessen Horowitz LSV Fund I-Q, L.P. | 10% Owner | 0Indirect | Nov 9, 2023 | 0 |
| Andreessen Horowitz LSV Fund I-B, L.P. | 10% Owner | 0Indirect | Nov 9, 2023 | 0 |
| Andreessen Horowitz LSV Fund II, L.P. | 10% Owner | 0Indirect | Nov 9, 2023 | 0 |
| AH Equity Partners LSV II, L.L.C. | 10% Owner | 0Indirect | Nov 9, 2023 | 0 |
| Andreessen Horowitz LSV Fund II-Q, L.P. | 10% Owner | 0Indirect | Nov 9, 2023 | 0 |
| Andreessen Horowitz LSV Fund II-B, L.P. | 10% Owner | 0Indirect | Nov 9, 2023 | 0 |
| AH Bio Fund II-B, L.P. | 10% Owner | 0Indirect | Nov 9, 2023 | 0 |
| AH Bio Fund II, L.P. | 10% Owner | 0Indirect | Nov 9, 2023 | 0 |
| AH Equity Partners Bio II, L.L.C. | 10% Owner | 0Indirect | Nov 9, 2023 | 0 |
| AH Bio Fund III, L.P. | 10% Owner | 0Indirect | Nov 9, 2023 | 0 |
| AH Equity Partners Bio III, L.L.C. | 10% Owner | 0Indirect | Nov 9, 2023 | 0 |
| AH Bio Fund III-Q, L.P. | 10% Owner | 0Indirect | Nov 9, 2023 | 0 |
| AH Bio Fund III-B, L.P. | 10% Owner | 0Indirect | Nov 9, 2023 | 0 |
| Giusti Kathryn E | Director | – | Nov 9, 2023 | 0 |
| Berns Paul L | Director | 0 | Nov 9, 2023 | 0 |
| Meanwell Clive | Director | – | Nov 9, 2023 | 0 |
| Borisy Alexis | Executive Chairman | 0 | Nov 9, 2023 | 0 |
| Merksamer Samuel J. | Director | – | Nov 9, 2023 | 0 |
| Yeshwant Krishna | Director | – | Nov 9, 2023 | 0 |
| Abernethy Amy | Director | 0 | Nov 9, 2023 | 0 |
| Horning Sandra | Director | 0 | Nov 9, 2023 | 0 |
| Conde Jorge | Director | 0Indirect | Nov 9, 2023 | 0 |
| Nallicheri Melanie | Chief Executive Officer | 0Indirect | Nov 9, 2023 | 0 |
| Ciarimboli Dina | General Counsel and Secretary | 0 | Nov 9, 2023 | 0 |
| Hedrick Eric | Chief Physician Executive | 627,000 | Jan 4, 2023 | 0 |
| Rubin Jami | Chief Financial Officer | 2,194,500 | Jan 4, 2023 | 0 |
| Meister Keith A. | Director, 10% Owner | – | Aug 3, 2021 | 0 |
| CMLS Holdings III LLC | Director, 10% Owner | – | Aug 3, 2021 | 0 |
| M-LSH III LLC | Director, 10% Owner | – | Aug 3, 2021 | 0 |
| C-LSH III LLC | Director, 10% Owner | – | Aug 3, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2021 (view filing)4:27 PM ET | Aug 1 | 2 days | Meister Keith A. and 4 othersDirector, 10% Owner | SSaleClass A common stock | −200.0K | $0.002 | −$400 | –13.5M after | Derivative |